activins and Adrenal Cortex Cancer

activins has been researched along with Adrenal Cortex Cancer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Jong, FH; Hofland, J1
Bavers, DL; Beuschlein, F; Bleasdale, SE; Hammer, GD; Looyenga, BD; Mutch, C; Nilson, JH; Parlow, AF1
Inagaki, K; Makino, H; Ogura, T; Otsuka, F; Suzuki, J; Takeda, M1
Roman, S1
de Herder, WW; de Jong, FH; de Krijger, RR; Hofland, J; Timmerman, MA; van Schaik, RH1
Hammer, GD; Looyenga, BD1
Huhtaniemi, I; Kananen, K; Markkula, M; McNeilly, A; Mikola, M; Rainio, EM1
Kennedy, A; McNicol, AM; Munro, LM1
Heikkilä, P; Kahri, AI; Liu, J; Voutilainen, R1

Reviews

2 review(s) available for activins and Adrenal Cortex Cancer

ArticleYear
Inhibins and activins: their roles in the adrenal gland and the development of adrenocortical tumors.
    Molecular and cellular endocrinology, 2012, Aug-15, Volume: 359, Issue:1-2

    Topics: Activins; Adrenal Cortex Neoplasms; Adrenal Glands; Animals; Cell Transformation, Neoplastic; Humans; Hyperplasia; Inhibins; TGF-beta Superfamily Proteins

2012
Adrenocortical carcinoma.
    Current opinion in oncology, 2006, Volume: 18, Issue:1

    Topics: Activins; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Humans; Inhibins; Mitotane; Positron-Emission Tomography; Vascular Endothelial Growth Factor A

2006

Other Studies

7 other study(ies) available for activins and Adrenal Cortex Cancer

ArticleYear
Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
    Molecular and cellular biology, 2003, Volume: 23, Issue:11

    Topics: Activins; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Animals; Apoptosis; Body Weight; Cachexia; DNA-Binding Proteins; Estradiol; Female; Humans; In Situ Hybridization; Inhibins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Mice, Transgenic; Ovarian Neoplasms; Ovariectomy; Phenotype; Receptors, LH; Smad2 Protein; Testosterone; Trans-Activators

2003
Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells.
    Endocrinology, 2004, Volume: 145, Issue:2

    Topics: Activins; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Bone Morphogenetic Protein 6; Bone Morphogenetic Proteins; Cell Division; Cell Line; Cholesterol Side-Chain Cleavage Enzyme; Culture Media, Conditioned; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cytochrome P-450 CYP11B2; Drug Synergism; Follistatin; Gene Expression; Humans; Mitogen-Activated Protein Kinases; Phosphoproteins; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Steroid 11-beta-Hydroxylase; Transfection; Tumor Cells, Cultured

2004
Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
    Clinical endocrinology, 2006, Volume: 65, Issue:6

    Topics: Activin Receptors, Type II; Activins; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adult; Carrier Proteins; Female; Follistatin; Gene Expression; Humans; Hyperplasia; Inhibin-beta Subunits; Inhibins; Male; Middle Aged; Proteoglycans; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Steroid 17-alpha-Hydroxylase

2006
Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery.
    Molecular endocrinology (Baltimore, Md.), 2007, Volume: 21, Issue:10

    Topics: Activins; Adrenal Cortex; Adrenal Cortex Neoplasms; Animals; Cell Cycle; Cell Transformation, Neoplastic; Cyclin D2; Cyclins; Down-Regulation; Female; Follicle Stimulating Hormone; Gene Expression Profiling; Gonadotropins; Inhibins; Insulin-Like Growth Factor I; Male; Mice; Mice, Knockout; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Repressor Proteins; Smad3 Protein; Testicular Neoplasms

2007
Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.
    Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:12

    Topics: Activins; Adrenal Cortex Neoplasms; Animals; Antigens, Polyomavirus Transforming; Castration; Cell Division; Disease Models, Animal; Estradiol; Female; Homeostasis; Immunohistochemistry; Inhibins; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Peptides; Progesterone; Promoter Regions, Genetic; Recombinant Fusion Proteins; Tumor Cells, Cultured

1996
The expression of inhibin/activin subunits in the human adrenal cortex and its tumours.
    The Journal of endocrinology, 1999, Volume: 161, Issue:2

    Topics: Activins; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adult; Cushing Syndrome; Female; Fetus; Growth Substances; Humans; Hyperplasia; Inhibins; Neoplasm Proteins

1999
Expression of activin A and its receptors in human pheochromocytomas.
    The Journal of endocrinology, 2000, Volume: 165, Issue:2

    Topics: Activin Receptors; Activins; Adrenal Cortex; Adrenal Cortex Neoplasms; Blotting, Northern; Bucladesine; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Humans; In Situ Hybridization; Inhibins; Pheochromocytoma; Receptors, Growth Factor; RNA, Messenger; Statistics, Nonparametric; Staurosporine; Tumor Cells, Cultured

2000